QGQian Gao

Qian Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qian Gao has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Liu

    Capital Medical University, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China

    4 shared publications
  • Zhenguo Zhai

    China-Japan Friendship Hospital

    4 shared publications
  • Guangliang Shan

    Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China

    2 shared publications
  • Jieping Lei

    Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China

    2 shared publications
  • Kaiyuan Zhen

    China‐Japan Friendship Hospital

    2 shared publications
  • Liwen Fang

    National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

    2 shared publications

Latest Publications

  • Performance of Western HA-VTE risk models in East Asian populations: a prospective multicenter study

    by Mengyao Li, Yuehan Duan, Zhaofei Chen, Jingrui Li, Yunfan Shi, Kaiyuan Zhen, Jing Ma, Lei Xia, Wei Wang, Qian Gao, et al.

    Hospital-associated venous thromboembolism (HA-VTE) causes significant morbidity, but risk prediction models are inconsistently validated, especially in non-Western populations. We prospectively validated 5 HA-VTE risk scores (Caprini, Padua, IMPROVE [International Medical Prevention Registry on Venous Thromboembolism], Kucher, and Intermountain) in a prospective multicenter cohort of 2948 adult inpatients from 17 Chinese hospitals. Symptomatic VTE events were recorded through 3 months of follow-up. The 90-day HA-VTE incidence was 2.54%. All 5 models showed moderate discrimination (area under the receiver operating characteristic curve [AUC], 0.726-0.759). Caprini, Padua, and Intermountain models did not differ significantly (DeLong test, P> .05). Caprini had the highest sensitivity (0.83) but classified 42.6% of patients as being at high risk. Padua and Intermountain favored specificity (0.75-0.81) with lower sensitivity (0.64-0.67). Clinical model selection should align with specific balances between sensitivity and utility. In surgical inpatients, Caprini performed best (AUC, 0.804; sensitivity, 0.90; negative predictive value, 1.00), although its more than 40 input variables limit practical use. Calibration was generally acceptable. Performance varied across subgroups. The prophylaxis subgroup showed attenuated performance, with reduced discrimination (eg, Caprini AUC decreased to 0.682) and less stable calibration. Western HA-VTE models have moderate predictive value in East Asian inpatient populations. Performance differs across subgroups. Local recalibration and development of simpler, population-specific scores are needed.


  • Influenza, pneumococcal, COVID-19 vaccine willingness and uptake with influencing factors in 38,184 chinese older adults in 2022: a nationwide cross-sectional study

    by Dong Liu, Yushi Zhang, Jieping Lei, Jie Li, Chunyan Xiang, Yaodie Peng, Yaoda Hu, Liwen Fang, Luzhao Feng, Guangliang Shan, et al.


  • Open Access

    Clinical Characteristics and Influencing Factors of New-Onset Atrial Fibrillation in Patients with Acute Pulmonary Embolism: A Case-Control Study

    by Rui Liang, Dong Liu, Yinong Chen, Ying Tang, Qian Gao, Wanmu Xie, Yihong Sun, Zhenguo Zhai

    Background: Atrial fibrillation (AF) after acute pulmonary embolism (PE) may lead to a poor prognosis. We conducted this study to explore influencing factors of new-onset AF in patients after acute PE. Methods: Patients with objectively confirmed acute PE at the China-Japan Friendship Hospital from first January 2015 to 31st May 2022 were retrospectively included in the study, and patients with new-onset AF confirmed by electrocardiography were defined as the case group. The control group was obtained from the above PE patients without new-onset AF in age matching. Patients with a history of AF, pulmonary hypertension, acute myocardial infarction, valvular heart disease and hyperthyroidism were excluded. Logistic regression was conducted to identify potential influencing factors for the development of new-onset AF in patients with acute PE. To assess the prediction value of potential variables, receiver operating characteristic curves were plotted. Results: Among 853 patients diagnosed with acute PE, 732 patients met the including criteria, and 29 patients with new-onset AF were identified. The median age of all patients was 74 years, with 77.6% being male. No statistically significant differences were observed between the case and control groups regarding demographic characteristics. Patients with new-onset AF had significantly enlarged right atrium, right ventricle and left atrium in echocardiography compared with control group, but no significant differences were observed in the diameter of the left ventricle and the proportion of left ventricular ejection fraction (LVEF) ≤ 40%. Right atrial enlargement (OR, 4.19; 95%CI, 1.24-15.09; P = 0.023), left atrial enlargement (OR, 14.76; 95%CI, 4.79–57.28; P < 0.001) and the simplified pulmonary embolism severity index (sPESI) (OR, 2.04; 95%CI, 1.19–3.67; P = 0.012) were associated with increased risk of new-onset AF. Conclusions: Both severity of acute PE and enlargement of left and right atrium were associated with an increased risk of new-onset AF in patients with acute PE. In patients with high-risk acute PE, greater vigilance is needed for the occurrence of new-onset AF.


  • Open Access

    Development and validation of a COVID-19 vaccination prediction model based on self-reporting results in Chinese older adults from September 2022 to November 2022: A nationwide cross-sectional study

    by Dong Liu, Yushi Zhang, Rui Liang, Jieping Lei, Ke Huang, Yaoda Hu, Liwen Fang, Luzhao Feng, Guangliang Shan, Min Wang, et al.

    It was common to see that older adults were reluctant to be vaccinated for coronavirus disease 2019 (COVID-19) in China. There is a lack of practical prediction models to guide COVID-19 vaccination program. A nationwide, self-reported, cross-sectional survey was conducted from September 2022 to November 2022, including people aged 60 years or older. Stratified random sampling was used to divide the dataset into derivation, validation, and test datasets at a ratio of 6:2:2. Least absolute shrinkage and selection operator and multivariable logistic regression were used for variable screening and model construction. Discrimination and calibration were assessed primarily by area under the receiver operating characteristic curve (AUC) and calibration curve. A total of 35057 samples (53.65% males and mean age of 69.64 ± 7.24 years) were finally selected, which constitutes 93.73% of the valid samples. From 33 potential predictors, 19 variables were screened and included in the multivariable logistic regression model. The mean AUC in the validation dataset was 0.802, with sensitivity, specificity, and accuracy of 0.732, 0.718 and 0.729 respectively, which were similar to the parameters in the test dataset of 0.755, 0.715 and 0.720, respectively, and the mean AUC in the test dataset was 0.815. There were no significant differences between the model predicted values and the actual observed values for calibration in these groups. The prediction model based on self-reported characteristics of older adults was developed that could be useful for predicting the willingness for COVID-19 vaccines, as well as providing recommendations in improving vaccine acceptance.


  • Open Access

    Case report: Pulmonary arterial hypertension in ENG-related hereditary hemorrhagic telangiectasia

    by Dong Liu, Feiya Xu, Qian Gao, Zhenguo Zhai

    A young adult woman presented with exertional dyspnea and she had had recurrent epistaxis for more than 10 years. On physical examination, cyanosis was noted on the lips, and telangiectasias were seen on the oral mucosa and fingertips. Routine investigations revealed iron deficiency anemia and slightly elevated bilirubin. The result of right heart catheterization was indicative of pulmonary arterial hypertension (PAH). Pulmonary angiography showed arteriovenous malformations of the left upper pulmonary artery, and anterior cerebral artery malformation was seen in cranial computed tomographic angiogram. Genetic testing revealed that she and her three daughters carried heterozygous variant of ENG c.1195-1196del p.Arg399GlyfsTer2, which is characterized by pulmonary and cerebral arteriovenous malformations. In addition, our patient had pulmonary hypertension (PH) that is commonly associated with ACVRL1 mutations, revealing her phenotype was not consistent with isolated ENG genetic mutations. Here, we report a case with hereditary hemorrhagic telangiectasia (HHT) combined with PAH, which is associated with interesting differential diagnosis and etiological analysis. We have discussed the relationship between PH and HHT and the characteristics of PAH in HHT patients.


  • Open Access

    Assessment of the Effect on Thromboprophylaxis with Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized Patients: A Pilot Study

    by Qian Gao, Kaiyuan Zhen, Lei Xia, Wei Wang, Yaping Xu, Chaozeng Si, Zhu Zhang, Fen Dong, Jieping Lei, Peiran Yang, et al.

    Background: To explore the feasibility and effectiveness of multifaceted quality improvement intervention based on the clinical decision support system (CDSS) in VTE prophylaxis in hospitalized patients. Methods: A randomized, department-based clinical trial was conducted in the department of respiratory and critical care medicine, orthopedic, and general surgery wards. Patients aged ≥18 years, without VTE in admission, were allocated to the intervention group and received regular care combined with multifaceted quality improvement intervention based on CDSS during hospitalization. VTE prophylaxis rate and the occurrence of hospital-associated VTE events were analyzed as primary and secondary outcomes. Results: A total of 3644 eligible residents were enrolled in this trial. With the implementation of the multifaceted quality improvement intervention based on the CDSS, the VTE prophylaxis rate of the intervention group increased from 22.93% to 34.56% (p < 0.001), and the incidence of HA-VTE events increased from 0.49% to 1.00% (p = 0.366). In the nonintervention group, the VTE prophylaxis rate increased from 24.49% to 27.90% (p = 0.091), and the incidence of HA-VTE events increased from 0.47% to 2.02% (p = 0.001). Conclusions: Multifaceted quality improvement intervention based on the CDSS strategy is feasible and expected to facilitate implementation of the recommended VTE prophylaxis strategies and reduce the incidence of HA-VTE in hospital. However, it is necessary to conduct more multicenter clinical trials in the future to provide more reliable real-world evidence.